515 related articles for article (PubMed ID: 16739203)
21. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement.
Brunner HI; Feldman BM; Urowitz MB; Gladman DD
J Rheumatol; 2003 Feb; 30(2):292-7. PubMed ID: 12563683
[TBL] [Abstract][Full Text] [Related]
22. Development of classification and response criteria for rheumatic diseases.
Singh JA; Solomon DH; Dougados M; Felson D; Hawker G; Katz P; Paulus H; Wallace C;
Arthritis Rheum; 2006 Jun; 55(3):348-52. PubMed ID: 16739201
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
Ward MM; Marx AS; Barry NN
J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
[TBL] [Abstract][Full Text] [Related]
24. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis.
Wallace CA; Giannini EH; Huang B; Itert L; Ruperto N; ; ;
Arthritis Care Res (Hoboken); 2011 Jul; 63(7):929-36. PubMed ID: 21717596
[TBL] [Abstract][Full Text] [Related]
25. Systemic lupus erythematosus activity. An operational definition.
Liang MH; Stern S; Esdaile JM
Rheum Dis Clin North Am; 1988 Apr; 14(1):57-66. PubMed ID: 3135558
[TBL] [Abstract][Full Text] [Related]
26. Visiting consultant clinics to study prevalence rates of juvenile rheumatoid arthritis and childhood systemic lupus erythematosus across dispersed geographic areas.
Kurahara DK; Grandinetti A; Fujii LL; Tokuda AA; Galario JA; Han MJ; Terrell MJ; Yamamoto KS; Yamaga KM; Person DA
J Rheumatol; 2007 Feb; 34(2):425-9. PubMed ID: 17295431
[TBL] [Abstract][Full Text] [Related]
27. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
Parodi A; Davì S; Pringe AB; Pistorio A; Ruperto N; Magni-Manzoni S; Miettunen P; Bader-Meunier B; Espada G; Sterba G; Ozen S; Wright D; Magalhães CS; Khubchandani R; Michels H; Woo P; Iglesias A; Guseinova D; Bracaglia C; Hayward K; Wouters C; Grom A; Vivarelli M; Fischer A; Breda L; Martini A; Ravelli A;
Arthritis Rheum; 2009 Nov; 60(11):3388-99. PubMed ID: 19877067
[TBL] [Abstract][Full Text] [Related]
28. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology.
Foeldvari I; Bidde M
J Rheumatol; 2000 Apr; 27(4):1069-72. PubMed ID: 10782839
[TBL] [Abstract][Full Text] [Related]
29. Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: Analysis of their ability to classify the American College of Rheumatology pediatric measures of response and the preliminary criteria for flare and inactive disease.
Ringold S; Bittner R; Neogi T; Wallace CA; Singer NG
Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1095-102. PubMed ID: 20506561
[TBL] [Abstract][Full Text] [Related]
30. The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials.
Abrahamowicz M; Fortin PR; du Berger R; Nayak V; Neville C; Liang MH
J Rheumatol; 1998 Feb; 25(2):277-84. PubMed ID: 9489819
[TBL] [Abstract][Full Text] [Related]
31. Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism.
Berntson L; Fasth A; Andersson-Gäre B; Kristinsson J; Lahdenne P; Marhaug G; Nielsen S; Pelkonen P; Svensson E;
J Rheumatol; 2001 Dec; 28(12):2737-43. PubMed ID: 11764226
[TBL] [Abstract][Full Text] [Related]
32. Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics.
Stone MA; Inman RD; Wright JG; Maetzel A
Arthritis Rheum; 2004 Jun; 51(3):316-20. PubMed ID: 15188313
[TBL] [Abstract][Full Text] [Related]
33. Prospective validation of the provisional criteria for the evaluation of response to therapy in childhood-onset systemic lupus erythematosus.
Brunner HI; Higgins GC; Wiers K; Lapidus SK; Olson JC; Onel K; Punaro M; Ying J; Klein-Gitelman MS; Giannini EH
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):335-44. PubMed ID: 20391479
[TBL] [Abstract][Full Text] [Related]
34. Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus.
Costenbader KH; Karlson EW; Mandl LA
J Rheumatol; 2002 Dec; 29(12):2545-50. PubMed ID: 12465149
[TBL] [Abstract][Full Text] [Related]
35. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
36. Defining Clinical Improvement in Adult and Juvenile Myositis.
Rider LG; Giannini EH; Harris-Love M; Joe G; Isenberg D; Pilkington C; Lachenbruch PA; Miller FW;
J Rheumatol; 2003 Mar; 30(3):603-17. PubMed ID: 12610824
[TBL] [Abstract][Full Text] [Related]
37. Preliminary definition of improvement in juvenile arthritis.
Giannini EH; Ruperto N; Ravelli A; Lovell DJ; Felson DT; Martini A
Arthritis Rheum; 1997 Jul; 40(7):1202-9. PubMed ID: 9214419
[TBL] [Abstract][Full Text] [Related]
38. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery.
Kozora E; Ellison MC; West S
Arthritis Rheum; 2006 Aug; 55(4):628-35. PubMed ID: 16874786
[TBL] [Abstract][Full Text] [Related]
39. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
Castrejón I; Tani C; Jolly M; Huang A; Mosca M
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
[TBL] [Abstract][Full Text] [Related]
40. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
